Skip to content
Factory direct · Export worldwide liifooroom@gmail.com
Hunan Xiangzhong Pharmaceutical Co., Ltd.
Hunan Premium Enterprise Global Digital Exhibition Platform

Projects

Projects & Cases

Official (Hunan MIIT): in 2024 Double-Crane invested 480 million yuan in an API base at Xiangzhong, which also obtained brexpiprazole registration and approval for sodium valproate sustained-release tablets.

Mail